Total Payments
$10,604
2024 Payments
$751.38
Companies
43
Transactions
340
Medicare Patients
413
Medicare Billing
$13,727
Payment Breakdown by Category
Food & Beverage$10,540 (99.4%)
Education$64.53 (0.6%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $10,540 | 335 | 99.4% |
| Education | $64.53 | 5 | 0.6% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Novo Nordisk Inc | $2,936 | 84 | $0 (2024) |
| Amgen Inc. | $1,038 | 21 | $0 (2024) |
| PFIZER INC. | $899.74 | 19 | $0 (2021) |
| AstraZeneca Pharmaceuticals LP | $823.68 | 34 | $0 (2020) |
| SANOFI-AVENTIS U.S. LLC | $556.00 | 9 | $0 (2018) |
| Kowa Pharmaceuticals America, Inc. | $488.26 | 29 | $0 (2019) |
| EISAI INC. | $393.62 | 26 | $0 (2019) |
| ABBVIE INC. | $304.26 | 4 | $0 (2023) |
| Allergan, Inc. | $300.75 | 14 | $0 (2020) |
| GlaxoSmithKline, LLC. | $259.80 | 6 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $751.38 | 9 | Novo Nordisk Inc ($145.16) |
| 2023 | $1,125 | 11 | Amgen Inc. ($243.19) |
| 2022 | $272.29 | 3 | Novo Nordisk Inc ($206.27) |
| 2021 | $250.12 | 4 | Novo Nordisk Inc ($111.49) |
| 2020 | $570.87 | 18 | AstraZeneca Pharmaceuticals LP ($233.29) |
| 2019 | $1,928 | 72 | Novo Nordisk Inc ($722.05) |
| 2018 | $2,804 | 112 | Novo Nordisk Inc ($788.41) |
| 2017 | $2,902 | 111 | Novo Nordisk Inc ($693.55) |
All Payment Transactions
340 individual payment records from CMS Open Payments — Page 1 of 14
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 11/21/2024 | Amneal Pharmaceuticals LLC | CREXONT (Drug) | Food and Beverage | In-kind items and services | $120.60 | General |
| Category: NEUROLOGY | ||||||
| 09/05/2024 | Neurocrine Biosciences, Inc. | INGREZZA (Drug) | Food and Beverage | In-kind items and services | $125.62 | General |
| Category: Neuropsychiatry | ||||||
| 08/29/2024 | ABIOMED | Impella (Device) | Food and Beverage | Cash or cash equivalent | $41.64 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 08/16/2024 | Noven Pharmaceuticals, Inc. | Xelstrym (Drug) | Food and Beverage | In-kind items and services | $17.45 | General |
| Category: ADHD | ||||||
| 07/29/2024 | ABIOMED | Impella (Device) | Food and Beverage | Cash or cash equivalent | $53.43 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 06/13/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $124.26 | General |
| Category: Obesity | ||||||
| 05/23/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $123.69 | General |
| Category: Cardio-renal | ||||||
| 05/08/2024 | Amgen Inc. | Repatha (Biological) | Food and Beverage | In-kind items and services | $123.79 | General |
| Category: Cardiology | ||||||
| 03/20/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $20.90 | General |
| Category: Diabetes | ||||||
| 11/07/2023 | GlaxoSmithKline, LLC. | AREXVY (Drug) | Food and Beverage | In-kind items and services | $116.71 | General |
| Category: RESPIRATORY | ||||||
| 10/17/2023 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $116.71 | General |
| Category: Obesity | ||||||
| 09/13/2023 | Amgen Inc. | Otezla (Drug) | Food and Beverage | In-kind items and services | $121.36 | General |
| Category: Inflammation | ||||||
| 08/29/2023 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $96.60 | General |
| Category: NEUROSCIENCE | ||||||
| 08/24/2023 | Lundbeck LLC | VYEPTI (Biological) | Food and Beverage | Cash or cash equivalent | $124.99 | General |
| Category: NEUROLOGY | ||||||
| 08/16/2023 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $115.92 | General |
| Category: DIABETES | ||||||
| 06/15/2023 | Amgen Inc. | Repatha (Biological) | Food and Beverage | In-kind items and services | $121.83 | General |
| Category: Cardiology | ||||||
| 03/20/2023 | Otsuka Pharmaceutical Development & Commercialization, Inc. | — | Food and Beverage | In-kind items and services | $15.47 | General |
| 03/10/2023 | IDORSIA PHARMACEUTICALS US INC | QUVIVIQ (Drug) | Food and Beverage | In-kind items and services | $80.46 | General |
| Category: INSOMNIA | ||||||
| 02/23/2023 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $96.68 | General |
| Category: Obesity | ||||||
| 02/03/2023 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $117.93 | General |
| Category: PSYCHIATRY | ||||||
| 10/19/2022 | Novo Nordisk Inc | Saxenda (Drug) | Food and Beverage | In-kind items and services | $120.96 | General |
| Category: Obesity | ||||||
| 03/01/2022 | Bayer HealthCare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $66.02 | General |
| Category: Cardio-renal | ||||||
| 02/16/2022 | Novo Nordisk Inc | Saxenda (Drug) | Food and Beverage | In-kind items and services | $85.31 | General |
| Category: Obesity | ||||||
| 08/04/2021 | AbbVie Inc. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $98.80 | General |
| Category: NEUROSCIENCE | ||||||
| 06/17/2021 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $111.49 | General |
| Category: Obesity | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2020 | 17 | 413 | 455 | $40,883 | $13,727 |
Total Patients
413
Total Services
455
Medicare Billing
$13,727
Procedure Codes
17
All Medicare Procedures & Services
17 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 59 | 74 | $12,358 | $5,398 | 43.7% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2020 | 13 | 13 | $2,340 | $1,572 | 67.2% |
| 93922 | Ultrasound study of arteries of both arms and legs | Office | 2020 | 15 | 15 | $4,500 | $1,057 | 23.5% |
| 99497 | Advance care planning by the physician or other qualified health care professional | Office | 2020 | 15 | 15 | $3,000 | $950.12 | 31.7% |
| 99422 | Online digital evaluation and management service, for an established patient, for up to 7 days, cumulative time during the 7 days; 11-20 minutes | Office | 2020 | 26 | 31 | $1,705 | $824.91 | 48.4% |
| 76775 | Ultrasound behind abdominal cavity, limited | Office | 2020 | 15 | 15 | $3,000 | $739.20 | 24.6% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 11 | 11 | $1,100 | $667.12 | 60.6% |
| 80061 | Blood test, lipids (cholesterol and triglycerides) | Office | 2020 | 34 | 35 | $2,450 | $460.55 | 18.8% |
| G2012 | Brief communication technology-based service, e.g. virtual check-in, by a physician or other qualified health care professional who can report evaluation and management services, provided to an established patient, not originating from a related e/m servic | Office | 2020 | 23 | 33 | $1,620 | $402.31 | 24.8% |
| 93000 | Routine ekg using at least 12 leads including interpretation and report | Office | 2020 | 27 | 27 | $2,133 | $376.86 | 17.7% |
| 83036 | Hemoglobin a1c level | Office | 2020 | 35 | 37 | $1,961 | $353.38 | 18.0% |
| G0008 | Administration of influenza virus vaccine | Office | 2020 | 16 | 16 | $720.00 | $280.78 | 39.0% |
| 99211 | Established patient office or other outpatient visit, typically 5 minutes | Office | 2020 | 14 | 17 | $663.00 | $270.32 | 40.8% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2020 | 42 | 47 | $987.00 | $138.54 | 14.0% |
| 82947 | Blood glucose (sugar) level | Office | 2020 | 28 | 29 | $870.00 | $111.89 | 12.9% |
| 81003 | Automated urinalysis test | Office | 2020 | 28 | 28 | $1,092 | $61.80 | 5.7% |
| 82570 | Creatinine level to test for kidney function or muscle injury | Office | 2020 | 12 | 12 | $384.00 | $61.26 | 16.0% |
About Dr. Evan Lipkis, MD
Dr. Evan Lipkis, MD is a Internal Medicine healthcare provider based in Glenview, Illinois. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 12/29/2005. The National Provider Identifier (NPI) number assigned to this provider is 1770560757.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Evan Lipkis, MD has received a total of $10,604 in payments from pharmaceutical and medical device companies, with $751.38 received in 2024. These payments were reported across 340 transactions from 43 companies. The most common payment nature is "Food and Beverage" ($10,540).
As a Medicare-enrolled provider, Lipkis has provided services to 413 Medicare beneficiaries, totaling 455 services with total Medicare billing of $13,727. Data is available for 1 year (2020–2020), covering 17 distinct procedure/service records.
Ad
Practice Information
- Specialty Internal Medicine
- Location Glenview, IL
- Active Since 12/29/2005
- Last Updated 01/07/2011
- Taxonomy Code 207R00000X
- Entity Type Individual
- NPI Number 1770560757
Products in Payments
- Saxenda (Drug) $932.91
- Ozempic (Drug) $742.38
- ELIQUIS (Drug) $593.10
- PRALUENT (Drug) $556.00
- FARXIGA (Drug) $513.50
- Victoza (Drug) $492.20
- Livalo (Drug) $488.26
- Prolia (Biological) $470.52
- Wegovy (Drug) $449.14
- Belviq (Drug) $393.62
- VRAYLAR (Drug) $264.28
- Repatha (Biological) $245.62
- SYMBICORT (Drug) $216.83
- Trintellix (Drug) $211.35
- CHANTIX (Drug) $197.90
- Aimovig (Biological) $197.47
- Kerendia (Drug) $189.71
- QSYMIA (Drug) $161.81
- Vascepa (Drug) $158.05
- NUEDEXTA (Drug) $139.82
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Internal Medicine Doctors in Glenview
Jose Nazari, Md, MD
Internal Medicine — Payments: $25,736
Internal Medicine $25,736
Dr. Thomas Ficho, M.d., Ph.d, M.D., PH.D
Internal Medicine — Payments: $20,710
Internal Medicine $20,710
Dr. Videsha Kulkarni, Md, MD
Internal Medicine — Payments: $14,537
Internal Medicine $14,537
Sheree Lipkis, Md, MD
Internal Medicine — Payments: $13,193
Internal Medicine $13,193
Dr. Najam Saqib, M.d, M.D
Internal Medicine — Payments: $9,427
Internal Medicine $9,427
Dr. Frank Weschler, M.d, M.D
Internal Medicine — Payments: $8,187
Internal Medicine $8,187